Anatomical Classification of Uveitis

Overview: Why Standardize the Nomenclature

Before the SUN Working Group published its criteria, different centers described the same patient's uveitis in different, non-interchangeable terms — making it difficult to compare outcomes across studies or even communicate clearly between clinicians. SUN (Standardization of Uveitis Nomenclature) was created to fix that: a consistent framework for the anatomic classification, activity grading, and outcome criteria used in describing uveitis, so that "anterior uveitis" or "grade 2+ cell" means the same thing everywhere.

The anatomic piece of that framework is the one clinicians reach for first. It sorts every case into one of four categories — anterior, intermediate, posterior, or panuveitis — based on where the inflammation is centered, not simply on which structures happen to show some involvement. That single distinction, primary site versus incidental spillover, is what makes the system usable at the bedside.

The Primary-Site Principle

SUN classifies uveitis by the anatomic site of the primary inflammatory activity, not by any single associated finding elsewhere in the eye. A case of anterior uveitis can still show a little vitreous haze; that alone doesn't make it intermediate uveitis. If anterior chamber inflammation is present alongside minimal vitreous haze that is judged to be spillover from the anterior process rather than primary pathology of its own, the case still gets classified as anterior uveitis with vitreous spillover — the mild vitreous finding does not reclassify it as intermediate uveitis or panuveitis.

The same logic runs in the other direction: when vitreous inflammation is itself the dominant, primary process — rather than a secondary spillover from the anterior chamber — the case is classified as intermediate uveitis, even if trace anterior chamber cell is also present. The question to ask is always "where is the disease actually centered?", not "which structures show any inflammation at all?"

Anterior Uveitis

Anterior uveitis is defined as inflammation primarily localized to the anterior chamber, involving the iris (iritis) or the iris together with the anterior ciliary body (iridocyclitis). SUN groups the iris and ciliary body together as the "anterior segment" for classification purposes — inflammation centered here defines anterior uveitis, while the pars plana and peripheral vitreous belong instead to the intermediate zone.

Iritis refers to inflammation confined to the iris alone, and the term is often used interchangeably with anterior uveitis in general practice. Iridocyclitis is the more specific term for anterior uveitis that also involves the anterior (pars plicata) portion of the ciliary body — distinguishing it from isolated iritis. On slit-lamp exam, the hallmark finding of active anterior uveitis is cell and flare in the anterior chamber: inflammatory cells and protein leakage from a disrupted blood-aqueous barrier, seen as illuminated particles suspended within a narrow slit beam.

Intermediate Uveitis

Intermediate uveitis is defined by SUN as inflammation with the vitreous as its primary site, often accompanied by involvement of the pars plana (the idiopathic subtype of which is called pars planitis). This anatomic definition is what separates it from anterior uveitis (chamber-centered) and posterior uveitis (choroid/retina-centered) — the disease process itself, not merely the presence of some vitreous cell, is what's centered in the vitreous cavity.

Posterior Uveitis

Posterior uveitis is anatomically defined as inflammation primarily involving the retina and choroid — encompassing chorioretinitis, retinitis, and choroiditis as overlapping descriptive terms for the same posterior-segment process. This category reflects the close anatomical and vascular relationship between the choroid and the overlying retina, and it can result from infectious causes (such as toxoplasma) as well as autoimmune processes.

Panuveitis

Panuveitis is the category reserved for diffuse involvement without a single predominant anatomical site: inflammation present simultaneously in the anterior chamber, the vitreous, and the retina or choroid. It's this three-compartment involvement — not simply "a lot of inflammation" — that distinguishes panuveitis from intermediate uveitis (vitreous-predominant) or an isolated anterior process. Panuveitis is frequently seen in systemic conditions such as Behçet disease, sarcoidosis, and Vogt-Koyanagi-Harada syndrome, all of which are covered in more depth elsewhere in this library.

Grading Anterior Chamber Activity

Alongside the anatomic classification, SUN standardized how anterior chamber inflammation is graded, giving clinicians a shared scale for describing disease activity and tracking response to treatment over time. The anterior chamber cell grading scale runs from 0 (no cells visible) up to a highest severity grade of 4+, corresponding to more than 50 cells seen per high-power field on slit-lamp exam. Because the scale is standardized rather than left to subjective description, a "grade 2+" documented at one visit can be meaningfully compared with a "grade 1+" at the next, giving an objective read on whether treatment is working.

SUN also defines two descriptors that don't depend on anatomic site at all. Onset is recorded as sudden or insidious, duration as limited (three months or less) or persistent (longer than three months), and course as acute, recurrent, or chronic: a recurrent pattern requires untreated quiet intervals of at least three months between episodes, while chronic uveitis relapses within three months of stopping therapy. Vitreous involvement gets its own activity scale too. The National Eye Institute's photographic vitreous haze scale, adopted by SUN as the counterpart to anterior chamber cell grading, also runs from grade 0 up to 4+, letting intermediate, posterior, and panuveitis cases be tracked just as objectively as anterior chamber activity.

Related Topics

Continue exploring Uveitis & Ocular Immunology: